Avitar, Inc. to Supply Save Mart Supermarket Chain With ORALscreen(TM)

California-based supermarket chain converts all locations

from urine to oral fluid for its drug testing needs.



Apr 02, 2001, 01:00 ET from Avitar, Inc.

    CANTON, Mass., April 2 /PRNewswire/ -- Avitar, Inc. (Amex:   AVR) announced
 today that they have agreed to supply ORALscreen, the world's first onsite
 oral fluid drugs of abuse test, to Save Mart, a California-based food store
 chain.  Save Mart, a supermarket chain with stores throughout California, is
 converting all pre-employment testing from a lab-based urine test to
 ORALscreen.
     "Hiring in the retail food industry is always a challenge because of the
 limited number of qualified applicants available.  We believe in the benefits
 of screening all applicants for drugs, but we had a lot of problems with our
 lab-based urine tests.  The results often take several days to get back, and
 we found we were losing a lot of good applicants to other companies," said
 James J. Pucci, Ph.D., Director of Risk Management and Food Safety for Save
 Mart.  "Since ORALscreen results we available in minutes, we can offer
 employment right on the spot and avoid losing desirable candidates.  By
 implementing ORALscreen immediately, we can now provide our customers with
 better service and achieve significant savings in both time and money for the
 Save Mart organization," added Pucci.
     "We recognize that ORALscreen, with its immediate onsite results, provides
 a competitive advantage to industries like retail food and convenience stores.
 We're excited that we could help Save Mart by greatly improving their method
 of employee selection," stated Michael J. DeFeo, Vice President of Marketing
 for Avitar.  "Our sales efforts in this market segment continue to pay
 dividends both for Avitar and our customers by providing a more competitive
 drug testing practice," added DeFeo.
 
     ABOUT SAVE MART
     Save Mart, headquartered in Modesto, CA, is a privately held company and
 operates retail food supermarkets.  Save Mart revenues for FY2000 is estimated
 at $1.5 billion. Save Mart has approximately 7,300 employees in 97 retail
 locations, marketed under the names of Save Mart, S-Mart Foods and Food
 Maxx throughout the state of California.
 
     ABOUT AVITAR
     Avitar, Inc. (Amex:   AVR) headquartered in Canton, Massachusetts, develops,
 manufactures and markets innovative medical devices based on proprietary core
 technologies for two distinctive markets: oral fluid diagnostics and
 customized polyurethane applications used in the wound dressing industry. Oral
 fluid diagnostics includes both the drugs-of-abuse testing market estimated to
 be worth $1.5 billion encompassing the corporate workplace and criminal
 justice markets and the $20 billion clinical diagnostics market.  Avitar's
 products include ORALscreen(TM), the world's first non-invasive, rapid, onsite
 oral fluid test for drugs-of-abuse, and HAIRscreen(TM), a laboratory based
 hair for detecting long-term drug abuse.  Additionally, the company
 manufactures and markets HYDRASORB(TM), an absorbent topical dressing for
 moderate to heavy exudating wounds.
 
     In 2001, the company formed strategic partnerships with DIPRO Diagnostic
 products GmbH and Pinkerton Security Group and acquired Texas-based BJR
 Security Service provider of canines trained to detect narcotics, explosives
 and firearms for markets that include education and the oil and petroleum
 industry.
 
     For more information, see Avitar's website at www.avitarinc.com.
 
     This release contains forward looking statements that are subject to risks
 and uncertainties including the development and marketing of new applications
 and other risks that are detailed from time to time in the Company's filings
 with the Securities and Exchange Commission.
 
 

SOURCE Avitar, Inc.
    CANTON, Mass., April 2 /PRNewswire/ -- Avitar, Inc. (Amex:   AVR) announced
 today that they have agreed to supply ORALscreen, the world's first onsite
 oral fluid drugs of abuse test, to Save Mart, a California-based food store
 chain.  Save Mart, a supermarket chain with stores throughout California, is
 converting all pre-employment testing from a lab-based urine test to
 ORALscreen.
     "Hiring in the retail food industry is always a challenge because of the
 limited number of qualified applicants available.  We believe in the benefits
 of screening all applicants for drugs, but we had a lot of problems with our
 lab-based urine tests.  The results often take several days to get back, and
 we found we were losing a lot of good applicants to other companies," said
 James J. Pucci, Ph.D., Director of Risk Management and Food Safety for Save
 Mart.  "Since ORALscreen results we available in minutes, we can offer
 employment right on the spot and avoid losing desirable candidates.  By
 implementing ORALscreen immediately, we can now provide our customers with
 better service and achieve significant savings in both time and money for the
 Save Mart organization," added Pucci.
     "We recognize that ORALscreen, with its immediate onsite results, provides
 a competitive advantage to industries like retail food and convenience stores.
 We're excited that we could help Save Mart by greatly improving their method
 of employee selection," stated Michael J. DeFeo, Vice President of Marketing
 for Avitar.  "Our sales efforts in this market segment continue to pay
 dividends both for Avitar and our customers by providing a more competitive
 drug testing practice," added DeFeo.
 
     ABOUT SAVE MART
     Save Mart, headquartered in Modesto, CA, is a privately held company and
 operates retail food supermarkets.  Save Mart revenues for FY2000 is estimated
 at $1.5 billion. Save Mart has approximately 7,300 employees in 97 retail
 locations, marketed under the names of Save Mart, S-Mart Foods and Food
 Maxx throughout the state of California.
 
     ABOUT AVITAR
     Avitar, Inc. (Amex:   AVR) headquartered in Canton, Massachusetts, develops,
 manufactures and markets innovative medical devices based on proprietary core
 technologies for two distinctive markets: oral fluid diagnostics and
 customized polyurethane applications used in the wound dressing industry. Oral
 fluid diagnostics includes both the drugs-of-abuse testing market estimated to
 be worth $1.5 billion encompassing the corporate workplace and criminal
 justice markets and the $20 billion clinical diagnostics market.  Avitar's
 products include ORALscreen(TM), the world's first non-invasive, rapid, onsite
 oral fluid test for drugs-of-abuse, and HAIRscreen(TM), a laboratory based
 hair for detecting long-term drug abuse.  Additionally, the company
 manufactures and markets HYDRASORB(TM), an absorbent topical dressing for
 moderate to heavy exudating wounds.
 
     In 2001, the company formed strategic partnerships with DIPRO Diagnostic
 products GmbH and Pinkerton Security Group and acquired Texas-based BJR
 Security Service provider of canines trained to detect narcotics, explosives
 and firearms for markets that include education and the oil and petroleum
 industry.
 
     For more information, see Avitar's website at www.avitarinc.com.
 
     This release contains forward looking statements that are subject to risks
 and uncertainties including the development and marketing of new applications
 and other risks that are detailed from time to time in the Company's filings
 with the Securities and Exchange Commission.
 
 SOURCE  Avitar, Inc.